Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ULTRAPLACAD

Financiado

Cerrado

ULTRAsensitive PLAsmonic devices for early CAncer Diagnosis

Cancer biomarkers circulating in body fluids have been shown to reflect the pathological process and for this reason can be used for cancer diagnosis, prognosis and choice for therapeutic interventions. It is proven that their det... ver más

31/10/2018

NATIONAL INSTITUTE...

6M€

Presupuesto del proyecto: 6M€

Líder del proyecto

ISTITUTO NAZIONALE DI BIOSTRUTTURE E BIOSISTE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 20 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-10-31

PHC-10-2014: Development of new diagnostic tools...

I+D

Cerrada hace 10 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

20 Participantes

NATIONAL INSTITUTE OFBIOSTRU...

833.49K€ | Lider

GS INIMA ENVIRONMENT

241.98K€ | Participante

AMIRES SRO

159.75K€ | Participante

Unife

213.75K€ | Participante

Proyectos interesantes

BRIGHT

Medical Technol...

Nanotechnology

4M€ Cerrado

CAMINEMS

Medical Technol...

Nanotechnology

Electronics

5M€ Cerrado

CTQ2017-84309-C2-2-R

Medical Technol...

Nanotechnology

102K€ Cerrado

CTQ2017-84309-C2-1-R

Medical Technol...

Nanotechnology

138K€ Cerrado

DNA-NANO-AB

Medical Technol...

Nanotechnology

251K€ Cerrado

CTQ2017-92226-EXP

Medical Technol...

Nanotechnology

Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 42 meses Fecha Inicio: 2015-04-21
Fecha Fin: 2018-10-31

Líder del proyecto

ISTITUTO NAZIONALE DI BIOSTRUTTURE E BIOSISTE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 6M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cancer biomarkers circulating in body fluids have been shown to reflect the pathological process and for this reason can be used for cancer diagnosis, prognosis and choice for therapeutic interventions. It is proven that their detection is a key to new minimal-invasive detection approaches. However, barriers to wide spread use of similar approaches are lack of test sensitivity, specificity and limited availability of low cost detection platforms. This project is focused at developing a compact plasmonic-based device with integrated microfluidic circuit and functionalized nanostructures for the detection of DNA, microRNA and tumor autoantibodies cancer biomarkers. The aim is to detect cancer biomarkers circulating in blood with improvement in sensitivity of factor up to 1000, reduction in cost of platform of factor ranging from 2 to 4 compared to today’s available techniques and analysis time less than 60 minutes. The proposed detection approache will provide ultrasensitive detection of biomolecular systems with no need for complex sample chemical modifications thus allowing direct and simple assays to be performed. Within the project a bimodal industrial prototype will be developed integrating novel surface plasmon resonance imaging and plasmon-enhanced fluorescence sensing technologies, respectively. Automated fabrication processes suitable for low cost mass production will be developed and applied to produce disposable integrated chips. Prototype will be specifically fabricated for early diagnosis and prognosis of colorectal cancer. The team includes partners holding cross-disciplinary competencies needed to achieve the proposed results, including two of the first five plasmon resonance groups in the world, the inventor of surface plasmon microscopy – also known as surface plasmon resonance imaging- and plasmon-enhanced fluorescence spectroscopy, and full European value chain including disposable chip and readout platforms design, development and manufacturing.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores